AGAWAM, Mass., Sept. 25, 2012 /PRNewswire/ -- Microtest Laboratories will present an environmental monitoring seminar and risk-assessment workshop to assist medical device and pharmaceutical manufacturers with building, validating, and maintaining their clean rooms and sterile manufacturing environments. Titled "Environmental Monitoring Seminar and...
CARY, N.C., Sept. 25, 2012 /PRNewswire/ -- Leveraging 18 years of experience in studying and shaping human health behavior, MicroMass Communications has formed a new consulting practice to help life science companies meet the growing demand for patient-centricity, an approach that...
LONDON, Sept. 25, 2012 /PRNewswire/ -- Xilinx, Inc. (NASDAQ: XLNX) is proud to announce that it was been presented with an Outstanding Achievement award at the Electronic Product Design e-Legacy Awards 2012 event in London earlier this month. Xilinx was...
CHICO, Calif., Sept. 25, 2012 /PRNewswire/ -- Landacorp announced today it will partner with Washington, D.C. insider, Hunter Bates, President of Bates Capital Group, to host a one-hour, live webinar titled; 2012 Election Preview: Will healthcare reform be overturned?...
JACKSONVILLE, Fla., Sept. 25, 2012 /PRNewswire/ -- Soft contact lenses are worn safely and comfortably by millions of people worldwide, and have a long history of providing wearers with a safe and effective form of vision correction when properly worn...
CASTLE ROCK, Colo., Sept. 25, 2012 /PRNewswire/ -- AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced that it will host a conference call and live audio webcast on Thursday, September 27, 2012, at 8:30 a.m. ET to...
QUEBEC CITY, Sept. 25, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the European Patent Office ("EPO") has granted a patent for the use of the ghrelin agonist, AEZS-130, related to methods and...
CARLSBAD, Calif., Sept. 25, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ:LIFE) today announced the launch of Pervenio™ Lung RS. First-of-its-kind, the molecular test has been documented to reliably identify early stage lung cancer patients who are at high risk for...
NEW YORK, Sept. 25, 2012 /PRNewswire/ -- IntraLinks® (NYSE: IL), a leading, global technology provider of inter-enterprise content management and collaboration solutions, today announced that Actelion Pharmaceuticals Ltd, an Allschwil/Basel, Switzerland headquartered biopharmaceutical company that focuses on the discovery, development, and...
MOUNTAIN VIEW, Calif., Sept. 25, 2012 /PRNewswire/ -- The increasing average age of the U.S. population is creating a vast market for medical treatment, especially minimally invasive procedures. In a fragile economy, patients prefer minimally invasive methods, boosting the...
